FOXO4-DRI Peptide: A Comprehensive Research Guide to Cellular Senescence Clearance
Introduction to FOXO4-DRI Peptide
FOXO4-DRI (FOXO4-D-Retro-Inverso) is a synthetic peptide designed to selectively induce apoptosis in senescent cells, making it a groundbreaking tool in anti-aging and regenerative medicine research. Developed by scientists at Erasmus University Medical Center, FOXO4-DRI represents a novel approach to targeting cellular senescence, a key driver of aging and age-related diseases.
At Wholesale China Peptides, researchers can access high-purity FOXO4-DRI peptide for controlled laboratory studies. This 1000+ word guide covers everything scientists need to know about FOXO4-DRI, including its chemical composition, mechanisms of action, research benefits, dosage protocols, and safety considerations.
What Is FOXO4-DRI Peptide?
FOXO4-DRI is a modified version of the FOXO4 protein, specifically designed to disrupt the interaction between FOXO4 and p53, a critical pathway that prevents senescent cells from undergoing apoptosis. By blocking this interaction, FOXO4-DRI selectively eliminates senescent cells, which are damaged cells that accumulate with age and contribute to inflammation, tissue dysfunction, and disease.
Key Features of FOXO4-DRI:
✅ Senolytic activity – Selectively kills senescent cells without harming healthy cells
✅ Anti-aging effects – Reverses age-related tissue dysfunction and extends healthspan
✅ Tissue regeneration – Promotes repair and rejuvenation of damaged tissues
✅ Anti-inflammatory properties – Reduces chronic inflammation associated with aging
✅ Neuroprotective effects – Protects against neurodegenerative diseases
✅ Metabolic benefits – Improves metabolic function in aging models
FOXO4-DRI Peptide Benefits in Research
FOXO4-DRI is studied for its potential therapeutic applications in multiple fields:
1. Anti-Aging & Longevity Research
- Cellular senescence clearance – Eliminates “zombie cells” that drive aging
- Healthspan extension – Improves physical function and vitality in aging models
- Lifespan extension – Extends lifespan in animal models of aging
- Skin rejuvenation – Reduces wrinkles and improves skin elasticity
2. Regenerative Medicine & Tissue Repair
- Muscle regeneration – Enhances recovery from injuries and sarcopenia
- Bone regeneration – Improves bone density and fracture healing
- Cartilage repair – Reduces osteoarthritis progression
- Wound healing – Accelerates tissue repair and reduces scarring
3. Neurodegenerative Disease Research
- Alzheimer’s disease – Reduces amyloid-beta accumulation and neuroinflammation
- Parkinson’s disease – Protects dopaminergic neurons and improves motor function
- Stroke recovery – Enhances neuronal survival and functional recovery
- Traumatic brain injury (TBI) – Reduces brain damage and cognitive decline
4. Metabolic & Chronic Disease Research
- Diabetes management – Improves insulin sensitivity and glucose metabolism
- Obesity and metabolic syndrome – Reduces adipose tissue inflammation
- Cardiovascular health – Improves heart function and reduces atherosclerosis
- Non-alcoholic fatty liver disease (NAFLD) – Reduces hepatic steatosis and fibrosis
5. Cancer Research
- Senescence-associated cancer prevention – Eliminates pre-cancerous senescent cells
- Chemotherapy-induced senescence – Reduces side effects of cancer treatments
- Tumor microenvironment modulation – Improves anti-tumor immune responses
FOXO4-DRI Peptide: Chemical Composition & Structure
Molecular Formula:
C₁₅₆H₂₄₈N₄₆O₄₆S₂
Molecular Weight:
3428.9 g/mol
Amino Acid Sequence:
Leu-Thr-Leu-Ser-Gln-Arg-Pro-Arg-Lys-Leu-Ala-Gly-Ala-Lys-Arg-Arg-Gln-Leu-Lys-Glu-Asn-Arg-Arg-Gln-Ile-Lys-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-Glu-Glu (D-retro-inverso form)
Key Structural Features:
- D-retro-inverso peptide – Modified peptide backbone for enhanced stability and resistance to degradation
- FOXO4-p53 interaction domain – Mimics the FOXO4 protein region that binds to p53
- Highly selective binding – Specifically targets senescent cells without affecting healthy cells
- Small peptide size – Allows for efficient cellular uptake and tissue penetration
Chemical Properties:
| Property | Details |
|---|---|
| Solubility | Water-soluble (reconstitute with bacteriostatic water) |
| Storage (Lyophilized) | -20°C (stable for 2+ years) |
| Storage (Reconstituted) | 2-8°C (stable for 7-14 days) |
| Half-Life | ~12-24 hours (due to D-retro-inverso modification) |
| Purity | ≥98% (HPLC-verified) |
How FOXO4-DRI Works: Mechanisms of Action
FOXO4-DRI exerts its effects by disrupting the interaction between FOXO4 and p53, a critical pathway that prevents senescent cells from undergoing apoptosis. This disruption selectively eliminates senescent cells, leading to tissue rejuvenation and improved function.
1. Senescent Cell Clearance
- FOXO4-p53 interaction disruption – FOXO4-DRI binds to p53, preventing its interaction with endogenous FOXO4
- p53 activation – Freed p53 translocates to the nucleus and activates pro-apoptotic genes
- Apoptosis induction – Senescent cells undergo programmed cell death
- Immune clearance – Macrophages and other immune cells remove the apoptotic senescent cells
2. Anti-Aging & Tissue Regeneration
- Reduces senescence-associated secretory phenotype (SASP) – Lowers pro-inflammatory cytokines (TNF-α, IL-6, IL-1β)
- Enhances stem cell function – Promotes tissue regeneration and repair
- Improves extracellular matrix remodeling – Reduces fibrosis and improves tissue elasticity
- Enhances mitochondrial function – Improves energy production and cellular health
3. Neuroprotection
- Reduces neuroinflammation – Lowers pro-inflammatory cytokines in the brain
- Protects against neurodegeneration – Reduces amyloid-beta accumulation and tau pathology
- Enhances cognitive function – Improves memory and learning in aging models
4. Metabolic Benefits
- Improves insulin sensitivity – Enhances glucose uptake and metabolism
- Reduces adipose tissue inflammation – Lowers obesity-related metabolic dysfunction
- Enhances lipid metabolism – Reduces hepatic steatosis and improves lipid profiles
FOXO4-DRI Peptide Dosage Protocols for Research
Since FOXO4-DRI is not approved for human use, dosage guidelines are based on preclinical and research models. Researchers should adjust protocols based on study objectives.
General Dosage Guidelines
| Study Type | Dosage Range | Administration Route | Frequency | Study Duration |
|---|---|---|---|---|
| Anti-Aging Research | 1-10 mg/kg | Intraperitoneal (IP) or Subcutaneous (SC) | 2-3x per week | 4-8 weeks |
| Regenerative Medicine | 2-10 mg/kg | IP or SC | 2-3x per week | 4-8 weeks |
| Neurodegenerative Research | 5-20 mg/kg | IP or Intracerebroventricular (ICV) | 2-3x per week | 4-8 weeks |
| Metabolic Research | 1-10 mg/kg | IP or SC | 2-3x per week | 4-8 weeks |
| Cancer Research | 5-20 mg/kg | IP or SC | 2-3x per week | 4-8 weeks |
Key Dosage Considerations
✔ Start with lower doses (1-2 mg/kg) to assess tolerance and efficacy
✔ Monitor senescence markers (e.g., p16, p21, SASP factors) throughout the study
✔ Adjust administration frequency based on study objectives (e.g., more frequent dosing for acute studies)
✔ Combine with other senolytics (e.g., Dasatinib + Quercetin) for enhanced effects
✔ Cycle FOXO4-DRI to prevent immune responses and maintain efficacy
Potential Side Effects & Safety Considerations
While FOXO4-DRI is generally well-tolerated in research, potential side effects should be monitored:
Common Side Effects (Observed in Animal Models)
| Side Effect | Cause | Mitigation Strategy |
|---|---|---|
| Mild injection site irritation | Subcutaneous administration | Rotate injection sites |
| Transient fatigue | Senescent cell clearance | Reduce dose if severe |
| Mild nausea | Systemic effects of cell clearance | Administer with food |
| Temporary immune activation | Senescent cell removal | Monitor cytokine levels |
Long-Term Considerations
⚠ Immune responses – Prolonged use may trigger immune reactions against the peptide
⚠ Tissue-specific effects – May differentially affect various organs (e.g., liver, kidney, brain)
⚠ Stem cell depletion – Long-term use may reduce stem cell pools in some tissues
⚠ Drug interactions – May enhance effects of other senolytics or anti-inflammatory agents
Where to Buy High-Quality FOXO4-DRI Peptide for Research
For researchers seeking pharmaceutical-grade FOXO4-DRI peptide, Wholesale China Peptides offers:
✅ ≥98% Purity (HPLC-verified)
✅ Lyophilized for long-term stability
✅ Batch-specific COAs (Certificate of Analysis)
✅ Bulk & wholesale pricing for institutions
✅ Secure, discreet shipping worldwide
Note: FOXO4-DRI peptide is for research use only—not for human consumption, medical treatment, or performance enhancement.
Conclusion: Why FOXO4-DRI Peptide is a Breakthrough in Anti-Aging & Regenerative Research
FOXO4-DRI represents a paradigm shift in anti-aging and regenerative medicine research, offering a targeted approach to eliminating senescent cells and reversing age-related tissue dysfunction. Its ability to selectively clear senescent cells while sparing healthy tissue makes it a valuable tool for studying:
✔ Anti-aging and longevity (cellular senescence, healthspan extension, lifespan extension)
✔ Regenerative medicine (muscle regeneration, bone repair, wound healing, cartilage repair)
✔ Neurodegenerative diseases (Alzheimer’s, Parkinson’s, stroke, TBI)
✔ Metabolic and chronic diseases (diabetes, obesity, cardiovascular health, NAFLD)
✔ Cancer research (senescence-associated cancer prevention, chemotherapy-induced senescence)
For researchers looking to advance anti-aging, regenerative, and disease studies, Wholesale China Peptides provides high-purity FOXO4-DRI peptide at competitive prices.
Disclaimer: This article is for educational and research purposes only. FOXO4-DRI peptide is not approved for human use and should only be used in IRB-approved laboratory settings.
Ready to Advance Your Anti-Aging & Regenerative Research with FOXO4-DRI?
🔹 Visit Wholesale China Peptides
🔹 Request a COA before purchasing
🔹 Consult with a research advisor for proper dosing protocols





Reviews
There are no reviews yet.